Fonte: Oral Diseases. Unidade: HRAC
Assuntos: CARCINOGÊNESE, ADENOMA PLEOMÓRFICO, ESPECTROMETRIA DE MASSAS, NEOPLASIAS DAS GLÂNDULAS SALIVARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA-SOUZA, Reydson Alcides de et al. Discovery proteomics reveals potential protein signature associated with malignant phenotype acquisition in pleomorphic adenoma. Oral Diseases, v. 29, n. 3, p. 1017-1027, 2023Tradução . . Disponível em: https://doi.org/10.1111/odi.14102. Acesso em: 22 ago. 2024.APA
Lima-Souza, R. A. de, Scarini, J. F., Lavareze, L., Emerick, C., Crescencio, L. R., Domingues, R. R., et al. (2023). Discovery proteomics reveals potential protein signature associated with malignant phenotype acquisition in pleomorphic adenoma. Oral Diseases, 29( 3), 1017-1027. doi:10.1111/odi.14102NLM
Lima-Souza RA de, Scarini JF, Lavareze L, Emerick C, Crescencio LR, Domingues RR, Leme AFP, Mariz BALA, Bastos DC, Machado RA, Tincani AJ, Del Negro A, Chone CT, Kowalski LP, Egal ESA, Altemani A, Mariano FV. Discovery proteomics reveals potential protein signature associated with malignant phenotype acquisition in pleomorphic adenoma [Internet]. Oral Diseases. 2023 ; 29( 3): 1017-1027.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1111/odi.14102Vancouver
Lima-Souza RA de, Scarini JF, Lavareze L, Emerick C, Crescencio LR, Domingues RR, Leme AFP, Mariz BALA, Bastos DC, Machado RA, Tincani AJ, Del Negro A, Chone CT, Kowalski LP, Egal ESA, Altemani A, Mariano FV. Discovery proteomics reveals potential protein signature associated with malignant phenotype acquisition in pleomorphic adenoma [Internet]. Oral Diseases. 2023 ; 29( 3): 1017-1027.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1111/odi.14102